All News

It might seem like common sense, but observing stringent hygiene protocols in hospital rooms can cut down on HAIs.

When pharmacy trade journals are talking about the same issues and the same solutions as they were 15 years ago, more than just the times are out of joint.

Jill Fitzgerald, PharmD, who is Drug Topics' CPE accreditor, was sworn in as chair-elect to the AACP Continuing Professional Education Section.

A recent report indicates that independent pharmacies are more prone to fraud and abuse than are chain stores.

Readers share an appreciation of JP, a defense of mail-order pharmacy, and how the $4 prescription has affected pharmacy.

Earlier this year, CVS Caremark began blocking about 30 drugs whose manufacturers were offering copay coupons. Express Scripts is taking similar steps.

Hospital readmissions constitute one of the most significant problems in healthcare. Medication therapy management is one way to reduce the problem.

The future may lead pharmacy practice in several new directions. Here are a few of the possibilities.

A survey of new Rx, new generic, and new OTC products

A sizable segment of the medication-using public seems to have decided that "natural" is better than anything pharmaceutical. But nature isn't always harmless.

FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.

As the drug-shortage crisis continues, pharmacists look for ways to stem the tide. In health systems, the most powerful solution results from collaboration across departments.

A roundup of OTC products to help manage the small hurts left by summer fun.

Fondaparinux shown to be safe for patients with renal impairment.

Kent Hospital, in Warwick, R.I., is stepping up its staff's awareness of safe injection practices.

Several drugstore chains are taking part in a pilot project with the CDC to provide HIV testing.

Teens are using OTC cough syrup, with DXM as an active ingredient, to get high. While the drug may be legal, its harmful effects are similar to those of illegal drugs.

DEA published its interim final rule on e-prescribing for controlled substances (EPCS) more than two years ago. While vendors work toward compliance, nationwide deployment of EPCS can only occur once both state and federal laws are aligned in all jurisdictions.

Short-term hormone replacement therapy is a relatively safe treatment for healthy, recently postmenopausal women, according to a new consensus statement.

An oral dose of modified-release tranexamic acid may offer an effective first-line therapy for patients with heavy menstrual bleeding, according to a recent study published online July 17 in The Annals of Pharmacotherapy.

A new formulation of the widely prescribed painkiller OxyContin has led drug abusers to shift to heroin, according to research results reported as a letter to the editor in the July 12 issue of the New England Journal of Medicine.

Several Congress members are concerned about the Department of Defense's use of the TRICARE mail-order pharmacy program administered by Express Scripts.

An ingestible sensor, formally referred to as the Ingestion Event Marker or IEM by Proteus Digital Health, that can report medication adherence and vital signs to physicians has been given the green light by FDA.

In a recent study, researchers found that rectal indomethacin significantly reduced the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients.

In patients with relapsing-remitting multiple sclerosis, interferon beta did not alleviate the progression of the disease, according to a new study.

More effective ways of combating pertussis in young infants, such as vaccinating pregnant women, should be considered, according to the authors of a new study.

FDA has approved ziv-aflibercept (Zaltrap, Sanofi and Regeneron Pharmaceuticals) injection for intravenous infusion, in combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI), for patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen.

FDA approved the first generic versions of montelukast sodium (Singulair, Merck) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.